Gout impacts around 4% of the U.S. adult population and is the most common form of inflammatory arthritis in men. The incidence of gout is increasing worldwide and may be as high as 9% in the elderly. Gout is a significant burden on the healthcare system, and is associated with both decreased work productivity and quality of life. With the ever-increasing impact of gout and its associated comorbidities on the population, investigation of novel translational mechanisms mediating gout flares as well as approaches to improving gout and hyperuricemia outcomes comprise an unmet and urgent medical need. The Administrative Core is responsible for the focusing the efforts our INvestigationS In Gout, Hyperuricemia, and comorbidiTies (INSIGHT) Center of Research Translation (CORT) on 4 research projects. The Administrative Core will facilitate knowledge translation of our theme, ?Gout, Hyperuricemia, and Associated Comorbidities? to researchers, clinicians, patients, trainees, and policy makers.The goal for the INSIGHT CORT is to improve the healthcare of patients and reduce the societal burden of gout and hyperuricemia by applying scientifically rigorous, state-of-the-art methodology to clinically important translational research questions. The Administrative Core aims to: (1) Provide oversight management, methodologic, and statistical support for projects comprising the INSIGHT CORT; (2) Conduct outstanding, innovative research projects drawing on unique strengths of the major partners at University of Alabama at Birmingham (UAB), Harvard University Medical School-affiliated Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH), and University of California San Diego (UCSD), using state-of-the-art tools from rheumatology, genetics, statistics, epidemiology, and outcomes research; (3) Foster the development of pilot and feasibility projects and the development and application of new evaluative, analytic, and translational methods to research in gout and hyperuricemia; (4) Promote the training of clinical investigators in the most current methods of translational research and evaluation applicable to gout and hyperuricemia through an enrichment program; (5) Maintain and enlarge the UAB Gout Rheumatology, Arthritis Database and Repository, a resource that will serve CORT projects proposed in this application; (6) Coordinate interactions with the Advisory Committees. To achieve the overall goal of the INSIGHT CORT and to accomplish its objectives, the Administrative Core will provide day-to-day scientific oversight of the program. It will coordinate the CORT's activities while facilitating interactions and collaborations, promoting scientific development, performing continuous evaluation of ongoing CORT programs, and setting the strategic agenda for the CORT.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Specialized Center (P50)
Project #
5P50AR060772-07
Application #
9568309
Study Section
Special Emphasis Panel (ZAR1)
Project Start
Project End
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
7
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Ryan, Evan M; Duryee, Michael J; Hollins, Andrew et al. (2018) Antioxidant properties of citric acid interfere with the uricase-based measurement of circulating uric acid. J Pharm Biomed Anal 164:460-466
Melles, Ronald B; Jorge, April M; Marmor, Michael F et al. (2018) Sharp decline in hydroxychloroquine dosing-analysis of 17,797 initiators from 2007 to 2016. Clin Rheumatol 37:1853-1859
Bursill, David; Taylor, William J; Terkeltaub, Robert et al. (2018) Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout. Arthritis Care Res (Hoboken) :
Jorge, April; Wallace, Zachary S; Zhang, Yuqing et al. (2018) All-Cause and Cause-Specific Mortality Trends of End-Stage Renal Disease due to Lupus Nephritis from 1995 to 2014. Arthritis Rheumatol :
Choi, Hyon; Neogi, Tuhina; Stamp, Lisa et al. (2018) New Perspectives in Rheumatology: Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert. Arthritis Rheumatol 70:1702-1709
McWherter, Charles; Choi, Yun-Jung; Serrano, Ramon L et al. (2018) Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling. Arthritis Res Ther 20:204
Sun, Mengying; Vazquez, Ana I; Reynolds, Richard J et al. (2018) Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities. Arthritis Res Ther 20:90
Mikuls, Ted R; Cheetham, T Craig; Levy, Gerald D et al. (2018) A Pharmacist-Led Intervention to Improve Gout Medication Adherence and Outcomes with Urate Lowering Therapy: A Site Randomized Trial. Am J Med :
Johnson, Tate M; Register, Kyle A; Schmidt, Cynthia M et al. (2018) Correlation of the Multi-Biomarker Disease Activity Score with Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken) :
England, Bryant R; Thiele, Geoffrey M; Anderson, Daniel R et al. (2018) Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ 361:k1036

Showing the most recent 10 out of 57 publications